3[1]CARSON P. β-blocker therapy in heart failure[J]. Cardiology Clinics, 2001, 19(2):267-278.
4[2]PACKER M, BRISTOW MR, COHN JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med, 1996, 334(21):1349-1355.
5[3]GREENBERG B, QUINONES MA, KOILPILLAI C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction[J]. Circulation, 1995, 91(10):2573-2581.
6[4]BRISTOW MR, O'CONNELL JB, GILBERT EM, et al. Dose-response of chronic beta blocker treatment in heart failure from either idiopathic dilated or ischaemic cardiomyopathy[J]. Circulation, 1994, 89(4):1632-1642.
7[5]HALL SA, CIGARROA CG, MARCOUS L, et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade[J]. J Am Coll Cardiol, 1995, 25(5):1154-1161.
8[6]HASENFUSS G, HOLIBARSH C, HERMANN HP, et al. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with nonfailing hearts and in patients with nonfailing hearts and in patients with dilated cardiomyopathy[J]. Eur Heart J, 1994, 15(1):164-170.
9[7]WAAGSTEIN F, HJALMARSON A, VARNAUSKAS E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy[J]. Br Heart J, 1975, 37(10):1022-1036.
10[8]ENGELMEIER RS, O'CONNELL JB, WALSH R, et al. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomised, placebo-controlled trial[J]. Circulation, 1985, 72(3):536-546.
